In addition, Soletti et al. report that pharmacological PPAR-γ activation protects from smoke-induced inflammation in vivo in mice, and attenuates the cellular and molecular intermediates of emphysema pathogenesis in humans. The gene discussed is PPARG; the disease is pulmonary emphysema.